Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 56Neoplasms 27Prostatic Neoplasms 18Lung Neoplasms 17Head and Neck Neoplasms 14Motor Activity 12Colorectal Neoplasms 12Gastrointestinal Neoplasms 9Ovarian Neoplasms 7Neoplasm Metastasis 7Endometrial Neoplasms 7Anxiety Disorders 7Lymphoma 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Pancreatic Neoplasms 5Pain 5Colonic Neoplasms 5Carcinoma, Renal Cell 5Smoking Cessation 4Sarcoma 4Recurrence 4Multiple Myeloma 4Melanoma 4Hematologic Neoplasms 4Fatigue 4Esophageal Neoplasms 4Depression 4Tobacco Use Cessation 3

Interventions

Surveys and Questionnaires 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neurofibroma, Plexiform × Surveys and Questionnaires × Clear all
NCT03531814 2024-06-11

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

National Institutes of Health Clinical Center (CC)

Phase NA Completed
12 enrolled 18 charts
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡